GIOVANNINI, MASSIMO
GIOVANNINI, MASSIMO
Mostra
records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.017 secondi).
Antiangiogenic strategies in breast cancer management
2010-01-01 Giovannini, M.; Aldrighetti, D.; Zucchinelli, P.; Belli, C.; Villa, E.
Clinical significance of skin toxicity due to EGFR-targeted Therapies
2009-01-01 Giovannini, M.; Gregorc, V.; Belli, C.; Roca, E.; Lazzari, C.; Vigano, M. G.; Serafico, A.; Villa, E.
Estrogen receptor (ER) and epidermal growth factor receptor (EGFR) as targets for dual lung cancer therapy: Not just a case?
2008-01-01 Giovannini, M.; Belli, C.; Villa, E.; Gregorc, V.
Immunomodulatory agents with antivascular activity in the treatment of non-small cell lung cancer: Focus on TLR9 agonists, IMiDs and NGR-TNF
2010-01-01 Corti, A.; Giovannini, M.; Belli, C.; Villa, E.
Malignant pleural mesothelioma: Current treatments and emerging drugs
2009-01-01 Belli, C.; Fennell, D.; Giovannini, M.; Gaudino, G.; Mutti, L.
Will antiangiogenic agents be a future for mesothelioma therapy?
2010-01-01 Belli, C.; Anand, S.; Panella, M.; Giovannini, M.; Tassi, G.; Fennell, D.; Mutti, L.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Antiangiogenic strategies in breast cancer management | 1-gen-2010 | Giovannini, M.; Aldrighetti, D.; Zucchinelli, P.; Belli, C.; Villa, E. | |
Clinical significance of skin toxicity due to EGFR-targeted Therapies | 1-gen-2009 | Giovannini, M.; Gregorc, V.; Belli, C.; Roca, E.; Lazzari, C.; Vigano, M. G.; Serafico, A.; Villa, E. | |
Estrogen receptor (ER) and epidermal growth factor receptor (EGFR) as targets for dual lung cancer therapy: Not just a case? | 1-gen-2008 | Giovannini, M.; Belli, C.; Villa, E.; Gregorc, V. | |
Immunomodulatory agents with antivascular activity in the treatment of non-small cell lung cancer: Focus on TLR9 agonists, IMiDs and NGR-TNF | 1-gen-2010 | Corti, A.; Giovannini, M.; Belli, C.; Villa, E. | |
Malignant pleural mesothelioma: Current treatments and emerging drugs | 1-gen-2009 | Belli, C.; Fennell, D.; Giovannini, M.; Gaudino, G.; Mutti, L. | |
Will antiangiogenic agents be a future for mesothelioma therapy? | 1-gen-2010 | Belli, C.; Anand, S.; Panella, M.; Giovannini, M.; Tassi, G.; Fennell, D.; Mutti, L. |